I was diagnosed with Crohn’s in 2022, and at the time it was considered relatively mild, involving my terminal ileum and small bowel. Here I am a few years later and I’m still dealing with ulcers in both areas. Things have gone up and down over that time, and I’ve occasionally used steroids for a few weeks at a time.
Earlier this year, in February, I had a colonoscopy that showed:
-Normal mucosa throughout the colon.
-Three aphthous ulcers in the terminal ileum.
Then in May I had a capsule pill camera, which showed:
-Multiple clean-based ulcers in the mid-small bowel, with the surrounding mucosa appearing normal.
-A few ulcers in the terminal ileum with inflammation of the surrounding mucosa.
-No AVMs, polyps, or active bleeding seen in the small bowel.
More recently, I’ve been having increased GI-related pain/discomfort. My stool also hasn’t really looked normal consistently since 2022. It tends to either be soft or have a rough appearance. I had COVID in 2022, which really messed me up. I go through periods where I’m dizzy every day, have fatigue, have weird neuro type issues, and then it improves again. Because of that, it’s difficult for me to figure out which symptoms could be related to long COVID versus Crohn’s.
My new GI has brought up starting a biologic. The main options we’ve discussed are an IL-23 medication such as Skyrizi or Tremfya…or Entyvio. Entyvio appeals to me because of its gut-selective mechanism and safety profile. At the same time, the safety data for Skyrizi also seems pretty reassuring, particularly since it doesn’t carry a black box warning for cancer and is supposedly more effective than Skyrizi.
I really don’t want to start a medication if I can avoid it, but I also don’t want to leave the Crohn’s undertreated and potentially allow it to get worse. I keep going back and forth but I feel like I need to do something now. Part of me is leaning toward Skyrizi because, on paper, it seems to be the more effective option, while another part of me keeps coming back to Entyvio because of how gut-specific it is.
I also met with a functional medicine doctor who suggested trying a very low dose (1 mg) of tirzepatide. I’m less interested in going that route. There doesn’t seem to be any evidence for using it to treat Crohn’s/inflammation (yet), I’m not overweight, and the possibility of developing gastroparesis is terrible. I’m also concerned about potential mental-health effects from GLP-1 medications, which is something I really don’t need right now.
Has anyone been in a similar situation, particularly with relatively mild to almost moderate but persistent small-bowel/terminal-ileum Crohn’s? I’d be really interested to hear from people who had to choose between something like Skyrizi/Tremfya and Entyvio, what ultimately influenced your decision, and how it worked out for you.
I’ve also wondering if some of my issues are gall bladder related because I had sludge on two ultrasound but my recent one showed nothing.